On ECHEMI
Home > Drugs > Suicheng Pharmaceutical Co., Ltd.
Suicheng Pharmaceutical Co., Ltd.
  • Founded in:

    1997-10-17
  • Country:

    China China
  • Address:

    No. 219, Qing'an Road, Xinzheng City
  • Tax NO.:

    91410100712635557P
  • Registered Funds:

    111.68 million yuan
  • Website:

  • Email:

Related Drugs
Colloidal Pectin Bismuth Capsules
Colloidal pectin bismuth is a complex of uncertain composition formed by pectin and bismuth.
Name Description Content CAS NO. Registered Holders
ColloidalBismuthPectin

After oral administration, it can form a protective film on the gastric mucosa and stimulate the gastric mucosal epithelial cells to secrete mucus, increasing the protective effect on the mucosa. In addition, it can kill Helicobacter pylori and promote the healing of gastritis.

More

After oral administration, it can form a protective film on the gastric mucosa and stimulate the gastric mucosal epithelial cells to secrete mucus, increasing the protective effect on the mucosa. In addition, it can kill Helicobacter pylori and promote the healing of gastritis.

2034-00-2 14
Fluconazole Tablets
The main ingredient of this product is fluconazole. Its chemical name is: α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazol-1-ylethanol.
Name Description Content CAS NO. Registered Holders
Fluconazole

This product belongs to the azole antifungal drug with a wide antifungal spectrum. Its mechanism of action is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane. It is effective against fungal infections in humans and various animals, such as Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, Trichophyton, Epidermophyton, etc.

More

This product belongs to the azole antifungal drug with a wide antifungal spectrum. Its mechanism of action is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane. It is effective against fungal infections in humans and various animals, such as Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, Trichophyton, Epidermophyton, etc.

86386-73-4 69
Fluconazole Tablets
The main ingredient of this product is fluconazole. Its chemical name is: α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazol-1-ylethanol.
Name Description Content CAS NO. Registered Holders
Fluconazole

This product belongs to the azole antifungal drug with a wide antifungal spectrum. Its mechanism of action is to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane. It is effective against fungal infections in humans and various animals, including Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, F. fischeri, Cladosporium carinii, etc.

More

This product belongs to the azole antifungal drug with a wide antifungal spectrum. Its mechanism of action is to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane. It is effective against fungal infections in humans and various animals, including Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, F. fischeri, Cladosporium carinii, etc.

86386-73-4 69
Vitamin B1 Injection
The main ingredient of this product is vitamin B1.
Name Description Content CAS NO. Registered Holders
Thiamine chloride

It combines with pyrophosphate in the body to form a coenzyme, participates in the oxidative decarboxylation reaction of pyruvate and α-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism. When it is deficient, oxidation is blocked to form pyruvate and lactic acid accumulation, which affects the body's energy supply and may lead to multiple peripheral neuritis (paresthesia, neuralgia, limb weakness, muscle aches and atrophy), as well as cardiovascular symptoms (palpitations, shortness of breath, chest tightness, cardiac hypertrophy, liver and lung congestion and peripheral edema) and digestive tract problems (loss of appetite, weakness, weight loss).

More

It combines with pyrophosphate in the body to form a coenzyme, participates in the oxidative decarboxylation reaction of pyruvate and α-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism. When it is deficient, oxidation is blocked to form pyruvate and lactic acid accumulation, which affects the body's energy supply and may lead to multiple peripheral neuritis (paresthesia, neuralgia, limb weakness, muscle aches and atrophy), as well as cardiovascular symptoms (palpitations, shortness of breath, chest tightness, cardiac hypertrophy, liver and lung congestion and peripheral edema) and digestive tract problems (loss of appetite, weakness, weight loss).

59-43-8 9
Vitamin B1 Injection
The main ingredient of this product is vitamin B1.
Name Description Content CAS NO. Registered Holders
Thiamine chloride

It combines with pyrophosphate in the body to form a coenzyme, participates in the oxidative decarboxylation reaction of pyruvate and α-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism. When it is deficient, oxidation is blocked to form pyruvate and lactic acid accumulation, which affects the body's energy supply and may lead to symptoms of the nervous and cardiovascular systems, such as multiple peripheral neuritis (paresthesia, neuralgia, limb weakness, muscle aches and atrophy, etc.), cardiovascular symptoms such as palpitations, shortness of breath, chest tightness, etc., and digestive symptoms such as decreased appetite leading to weakness and weight loss.

More

It combines with pyrophosphate in the body to form a coenzyme, participates in the oxidative decarboxylation reaction of pyruvate and α-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism. When it is deficient, oxidation is blocked to form pyruvate and lactic acid accumulation, which affects the body's energy supply and may lead to symptoms of the nervous and cardiovascular systems, such as multiple peripheral neuritis (paresthesia, neuralgia, limb weakness, muscle aches and atrophy, etc.), cardiovascular symptoms such as palpitations, shortness of breath, chest tightness, etc., and digestive symptoms such as decreased appetite leading to weakness and weight loss.

59-43-8 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.